TRANSPLANTED INTO A HUMAN. SADLY, THAT MAN FROM WEYMOUTH DIED LESS THAN TWO MONTHS LATER, ONLY ON FIVE. I SPOKE WITH ONE DOCTOR WHO PERFORMED THAT PROCEDURE ABOUT WHAT HAPPENED AND WHERE THIS ...

Surgeons perform kidney transplant with modified pig kidney at Massachusetts General Hospital Surgeons in Massachusetts have become the first to complete a transplant of a genetically modified pig ...

The multidisciplinary panel thought the tumor’s proximity to the liver made it a bad candidate for percutaneous cryoablation therapy. A hand-assisted laparoscopic right partial nephrectomy was ...

Doctors at Massachusetts General Hospital on Thursday said they have transplanted a genetically modified pig kidney into a human living with kidney disease, the first such procedure in the world. The ...

BOSTON – For the first time ever, surgeons at Massachusetts General Hospital in Boston transplanted a pig kidney into a living human patient. Mass General said Thursday the procedure was the first ...

A New Hampshire man fought for the chance at a pig kidney transplant, spending months getting into good enough shape to be part of a small pilot study of a highly experimental treatment. His effort ...

Boston has once again made medical history. The renowned hospital Mass General Hospital announced Thursday the world’s first successful transplant of a genetically edited pig kidney into a 62-year-old ...

Richard Slayman, the first living person in the world to receive a kidney transplant from a pig, has been discharged from Massachusetts General Hospital and is continuing his recovery at home. Slayman ...

Earlier this week, former NBA star and current NBC NBA analyst Dwyane Wade shared that he has finally started to feel better following surgery to have a cancerous mass on his liver removed. During the ...

An investigation of management patterns after initial radiographic diagnosis of small renal masses showed that early urologist referral was associated with guideline-concordant care. Objectives: ...

Acquires next generation tissue-targeted C3d-Factor H fusion protein complement inhibitor from Q32 Bio Phase 2 basket trial ...